GM patients inject hope into prostate cancer research

Modified common cold viruses are to be injected directly into prostate tissue, making the recipients officially genetically modified organisms.


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Men with prostate cancer are to be turned into genetically modified organisms (GMOs) as part of a groundbreaking attempt to cure the disease. The new trial, which was announced at the 3rd Global Conference for Cancer Organisations, in Brighton, will use gene therapy to make the cells a target for chemotherapy.

The research will be undertaken at the Queen Elizabeth Hospital, Birmingham, and the trial will be divided into two stages. First, the men will have a genetically engineered common cold virus carrying the gene for nitroreductase injected directly into their prostate gland. The prostate will be removed two days later so as to calculate the optimum dosage levels.

In the second phase, more cancer sufferers will be injected with the virus before being given a 'pro-drug', which is only active in the presence of a protein 'trigger' — nitroreductase. The pro-drug will be CB1954, a derivative of mustard and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio